Work is ongoing in the following areas:

  • Development of nanoparticle based immunotherapies for drug sensitive and drug resistant forms of tuberculosis

  • Development of inhalable particles for treatment of tuberculosis

  • Studies of the interaction of nanoparticles and immune cells in the context of infectious diseases

  • Synthesis and evaluation of nanoparticles for infectious diseases drug delivery